BIOCON LIMITED INDIA

BIOCON LIMITED INDIA is a manufacturer.

Company Introduction:

Biocon Limited India is a leading global biopharmaceutical company based in Bengaluru, India. It specializes in the research, development, manufacturing, and marketing of biopharmaceuticals, including biosimilars, novel biologics, and complex APIs (Active Pharmaceutical Ingredients).

The company's core focus areas include diabetes, oncology, immunology, and other therapeutic segments. Biocon is known for its vertically integrated business model, which encompasses discovery, development, manufacturing, and commercialization of its products. It operates state-of-the-art manufacturing facilities that produce a wide range of pharmaceutical products for global markets. Biocon is committed to making affordable access to life-saving biopharmaceuticals a reality worldwide.

Biocon Limited India manufactures and sells a diverse range of biopharmaceutical products. These include biosimilars such as Insulin Glargine, Recombinant Human Insulin, Insulin Aspart, Trastuzumab, Bevacizumab, Pegfilgrastim, Adalimumab, and Etanercept. The company also offers branded formulations targeting therapeutic areas like diabetes, oncology, nephrology, and immunology. A key novel biologic product is Itolizumab. Additionally, Biocon produces Active Pharmaceutical Ingredients (APIs) for various small molecules, including statins and immunosuppressants.